Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|June 22, 2016

CPhI Accepting Applications for 2016 Pharma Awards

The annual CPhI Pharma Awards honor companies and individuals driving the pharmaceutical industry forward through innovation, new approaches, technologies, and strategies.

CPhI is now accepting applications for the 2016 CPhI Pharma Awards. The Pharma Awards are presented annually on the first night of CPhI Worldwide at the Pharma Awards Gala. Applications will be accepted until August 21, 2016, and individuals and companies from across the industry are encouraged to apply, CPhI said in a June 22, 2016 press announcement.

Now in their 13th year, the CPhI Pharma Awards honor companies and individuals driving the pharmaceutical industry forward through innovations, new approaches, technologies, and strategies. The 2016 awards are split into 12 categories including:

  • Excellence in Pharma: API Development

  • Excellence in Pharma: Formulation and Excipients

  • Excellence in Pharma: Packaging 

  • Excellence in Pharma: Drug Delivery Devices

  • Excellence in Pharma: Contract Services & Outsourcing 

  • Excellence in Pharma: Regulatory Procedures and Compliance

  • Excellence in Pharma: Supply Chain, Logistics & Distribution 

  • Excellence in Pharma: Analysis, Testing, and Quality Control

  • Excellence in Pharma: Bioprocessing

  • Excellence in Pharma: Manufacturing Technology and Equipment

  • Excellence in Pharma: Corporate Social Responsibility

  • Excellence in Pharma: CEO of the Year 

This list includes four new categories, created with the intention of accommodating increasing demand across the pharma supply chain, CPhI noted. The new categories, honoring excellence in pharma, include Drug Delivery and Devices, Regulatory Procedures and Compliance, Analysis, Testing and Quality Control, and Corporate Social Responsibility.

Those interested can submit applications on the CPhI awards website. Finalists will be announced in September 2016. The CPhI Worldwide conference will take place from Oct. 4–6, 2016 in Barcelona, Spain. CPhI, Pharmaceutical Technology, and BioPharm International are all UBM plc brands.

Source: CPhI 


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.